Definium Therapeutics DFTX
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 9th percentile, 5-year average -4.2x
Above its usual level · 70th percentile, 5-year average 4.0x
#4283 of 5331 stocks by PB (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 4.54 | – | 3.99 | 70% (pricier than usual) | #4283 of 5331 (1 = cheapest) |
| PE | -10.99 | -15.79 | -4.24 | 9% (cheaper than usual) | – |
| PS | – | 276.67 | 0.00 | – | – |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on DFTX.
Sign in to join the discussion.